ReviewDrug design, development and therapy2024

Updated Evaluation of Agalsidase Alfa Enzyme Replacement Therapy for Patients with Fabry Disease: Insights from Real-World Data.

Sandro Feriozzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.